News Column

Guangdong Taiantang H1 Net Up 50%

August 19, 2014

SHANTOU, August 19, SinoCast -- Guangdong Taiantang Pharmaceutical Co., Ltd. (SZSE: 002433) revealed operating revenue of CNY 444 million in the first half of 2014, rising 54.53%. Net profit attributable to shareholders reached CNY 59.7441 million, hiking 50.29%. Basic EPS were CNY 0.11, thanks to expanding drug sales volume and increasing revenue from Chinese herbal pieces. In the reporting period, sales value of Chinese herbal medicines jumped 343.22% to CNY 160 million.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters